Jim joined Sandoz in 2013 where he serves as Director of Clinical Development and Medical Affairs. He has more than ten years of pharmaceutical industry experience and has held a variety of positions involved in clinical research and medical education. At Sandoz, he supports biosimilar clinical research programs in the US and has been involved in biosimilar education working with multiple stakeholders including physicians, patients, pharmacists, and payers. He has also supported efforts to pass state legislation allowing pharmacy level biosimilar substitution and has worked on biosimilar policy issues with federal legislators.
Jim began his career doing biomedical research at UT Southwestern Medical Center in Dallas, Texas. He earned his PhD in Molecular Biology at Carnegie Mellon University, Pittsburgh, PA.